138 filings
Page 2 of 7
EFFECT
dg1lp85g
30 May 23
Notice of effectiveness
12:15am
CORRESP
3t8tq sbak9jyjtkbi
24 May 23
Correspondence with SEC
12:00am
UPLOAD
pi3ui9p1s2
18 May 23
Letter from SEC
12:00am
8-K
0wjxzrktoj6aijgq
11 May 23
Milestone Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Corporate Update
7:25am
S-8
cf2e 6aag0plcs5m28w4
28 Apr 23
Registration of securities for employees
5:10pm
ARS
tm0bk bh3pde5
28 Apr 23
Annual report to shareholders
5:01pm
DEFA14A
spq34rrk5
28 Apr 23
Additional proxy soliciting materials
4:20pm
8-K
jjjr x76e27z56hk12
31 Mar 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9:29am
8-K
in4x36e
29 Mar 23
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Corporate Update
9:21am
8-K
8zq06ye 0tk
28 Mar 23
Milestone Pharmaceuticals Announces $125 Million Strategic Financing with RTW Investments to Support the Advancement of Etripamil for PSVT
7:00am
8-K
fx99tbd tbwxmdr
27 Mar 23
Entry into a Material Definitive Agreement
5:17pm
8-K
xb15btq o2qd
10 Mar 23
Regulation FD Disclosure
5:26pm
8-K
kn87kejsd76v7 s2ib3
7 Mar 23
Regulation FD Disclosure
9:12am
8-K
g0x 0lums
6 Dec 22
Departure of Directors or Certain Officers
4:37pm
8-K
y25ybb66qol0
10 Nov 22
Milestone Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Clinical and Corporate Update
4:01pm